Genworth Financial (GNW) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
24 Mar, 2026Executive summary
Advanced strategic priorities in 2025, focusing on capital generation from Enact, expansion of CareScout, and maintaining self-sustaining legacy insurance businesses.
Returned $245 million to shareholders via share repurchases and received $407 million in free cash flows from Enact, maintaining a strong PMIERS sufficiency ratio.
Launched new products and services, including Care Assurance and expanded CareScout Quality Network, and acquired Seniorly to accelerate direct-to-consumer growth.
Enhanced claims experience for long-term care policyholders and implemented new recognition programs for associates.
Voting matters and shareholder proposals
Stockholders will vote on: election of ten directors, advisory vote on executive compensation, approval of the 2026 Associate Stock Purchase Plan, and ratification of KPMG LLP as independent auditor.
Board recommends voting FOR all proposals.
No shareholder proposals will be presented due to non-compliance with bylaw requirements.
Board of directors and corporate governance
Board consists of ten members, nine of whom are independent; diverse in tenure, background, and skills.
Board committees: Audit, Compensation, Governance, Risk, and Technology—all fully independent.
Annual board and committee self-evaluations, robust succession planning, and regular director education.
Non-Executive Chair structure maintained for effective oversight.
Latest events from Genworth Financial
- Enact drove Q4 profits and capital returns; CareScout expanded as LTC losses weighed on results.GNW
Q4 202524 Feb 2026 - Q2 2024 adjusted operating income rose to $125M, driven by Enact and strong capital returns.GNW
Q2 20242 Feb 2026 - Q3 net income rose to $85M, driven by Enact strength, LTC actions, and CareScout growth.GNW
Q3 202415 Jan 2026 - Q1 2025 net income was $54M, driven by Enact, CareScout growth, and capital returns.GNW
Q1 202523 Dec 2025 - Q4 net loss of $1M, strong Enact results, and $565M in share repurchases amid LTC headwinds.GNW
Q4 202421 Dec 2025 - Shareholders to vote on board, pay, incentive plan, auditor, and governance changes after a strong year.GNW
Proxy Filing1 Dec 2025 - Strong 2024 results, expanded aging care, and key governance proposals drive shareholder value.GNW
Proxy Filing1 Dec 2025 - Board recommends approval of all key proposals, including director elections and compensation.GNW
Proxy Filing1 Dec 2025 - Q2 2025 net income was $51M, with $94M in capital returns and CareScout network expansion.GNW
Q2 202516 Nov 2025